Malignant Endometrial Neoplasm — Trials

Malignant Endometrial Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,198 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 359
Recruiting: 203
Ph III recruiting: 21
Growth YoY: +3.8%
Industry share: 33%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (112)

clinicaltrialsPublishedShowing 451–461 of 461 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04403867	The Role of Micrometastasis and Isolated Tumor Cells (ITCs) in Endometrial and Cervical Cancer. A Multicenter Study.(ITCMicroUtCa)	recruiting	—	500	Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER	1	Aug 17, 2022	clinicaltrials
NCT05489848	Chemotherapy vs Chemoradiotherapy for Post-operative Endometrial Cancer Patients With P53-mutation	not yet recruiting	Phase 2 / Phase 3	294	Fudan UniversityOTHER